U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 100

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:161276240
GRCh38:
Chr1:161306450
MPZG155RCharcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B,
Charcot-Marie-Tooth disease dominant intermediate D
Uncertain significance
(Jan 1, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr1:161277070
GRCh38:
Chr1:161307280
MPZE71GCharcot-Marie-Tooth disease type 1BUncertain significance
(Mar 31, 2023)
no assertion criteria provided
3.
GRCh37:
Chr1:161275960
GRCh38:
Chr1:161306170
MPZCharcot-Marie-Tooth disease type 1BLikely pathogenic
(Nov 15, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr1:161276545
GRCh38:
Chr1:161306755
MPZD134VCharcot-Marie-Tooth disease type 1BPathogenic
(May 4, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr1:161276256
GRCh38:
Chr1:161306466
MPZCharcot-Marie-Tooth disease type 1BLikely pathogenic
(May 4, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr1:161276669
GRCh38:
Chr1:161306879
MPZG93RCharcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease, type ILikely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr1:161276643
GRCh38:
Chr1:161306853
MPZW101CCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1BLikely pathogenic
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr1:161275306
GRCh38:
Chr1:161305516
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Aug 24, 2021)
criteria provided, conflicting interpretations
9.
GRCh37:
Chr1:161275297
GRCh38:
Chr1:161305507
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr1:161274914
GRCh38:
Chr1:161305124
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr1:161274763
GRCh38:
Chr1:161304973
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr1:161277098
GRCh38:
Chr1:161307308
MPZI62VNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr1:161275231
GRCh38:
Chr1:161305441
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
14.
GRCh37:
Chr1:161275144
GRCh38:
Chr1:161305354
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr1:161275564
GRCh38:
Chr1:161305774
MPZRoussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr1:161275325
GRCh38:
Chr1:161305535
MPZRoussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr1:161276502
GRCh38:
Chr1:161306712
MPZE148DRoussy-Lévy syndrome, Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
18.
GRCh37:
Chr1:161276543
GRCh38:
Chr1:161306753
MPZI135LCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1BLikely pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr1:161276584
GRCh38:
Chr1:161306794
MPZD121GCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1BUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr1:161277088
GRCh38:
Chr1:161307298
MPZT65NCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1BPathogenic/Likely pathogenic
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr1:161276263
GRCh38:
Chr1:161306473
MPZCharcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease, type ILikely benign
(Jan 10, 2023)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr1:161277090-161277092
GRCh38:
Chr1:161307300-161307302
MPZF64delCharcot-Marie-Tooth disease type 1BLikely pathogenic
(Jan 17, 2023)
criteria provided, single submitter
23.
GRCh37:
Chr1:161277181
GRCh38:
Chr1:161307391
MPZT34ICharcot-Marie-Tooth disease type 1BLikely pathogenic
(May 4, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr5:148408235
GRCh38:
Chr5:149028672
SH3TC2Inborn genetic diseases, Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 1B
Conflicting interpretations of pathogenicity
(Dec 23, 2022)
criteria provided, conflicting interpretations
25.
Charcot-Marie-Tooth disease type 1B, Migraine, familial hemiplegic, 2, Paragangliomas 3,
Variegate porphyria
Pathogenic
(Apr 13, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr1:161276518
GRCh38:
Chr1:161306728
MPZT143MNeuropathy, congenital hypomyelinating, 2, Inborn genetic diseases, not provided,
Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Uncertain significance
(Aug 23, 2023)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr1:161275751
GRCh38:
Chr1:161305961
MPZA221VCharcot-Marie-Tooth disease, type IUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr1:161276549
GRCh38:
Chr1:161306759
MPZP133TCharcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease, type I
Pathogenic/Likely pathogenic
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr1:161276546
GRCh38:
Chr1:161306756
MPZD134NCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B, not provided
Conflicting interpretations of pathogenicity
(Jun 15, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr1:161275705-161275707
GRCh38:
Chr1:161305915-161305917
MPZK236delCharcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, Inborn genetic diseases,
Charcot-Marie-Tooth disease type 2I, not provided
Conflicting interpretations of pathogenicity
(Jan 9, 2023)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr1:161276645
GRCh38:
Chr1:161306855
MPZW101RCharcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease, type ILikely pathogenic
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr1:161279744
GRCh38:
Chr1:161309954
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr1:161277205
GRCh38:
Chr1:161307415
MPZP26LNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B,
Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Apr 20, 2022)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr1:161276199
GRCh38:
Chr1:161306409
MPZCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease,
not provided, Neuropathy, congenital hypomyelinating, 2, not specified
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr1:161275614
GRCh38:
Chr1:161305824
MPZG267SNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr1:161275471
GRCh38:
Chr1:161305681
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D
Conflicting interpretations of pathogenicity
(Mar 1, 2023)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr1:161275415
GRCh38:
Chr1:161305625
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr1:161275098
GRCh38:
Chr1:161305308
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Benign/Likely benign
(May 13, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr1:161275042
GRCh38:
Chr1:161305252
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Benign/Likely benign
(May 13, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr1:161274985
GRCh38:
Chr1:161305195
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr1:161274923
GRCh38:
Chr1:161305133
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B,
Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr1:161274905
GRCh38:
Chr1:161305115
MPZNeuropathy, congenital hypomyelinating, 2, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
Benign
(May 13, 2021)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr1:161274712
GRCh38:
Chr1:161304922
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr1:161274646
GRCh38:
Chr1:161304856
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr1:161274618
GRCh38:
Chr1:161304828
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, not provided
Conflicting interpretations of pathogenicity
(May 1, 2023)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr1:161274592
GRCh38:
Chr1:161304802
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease dominant intermediate D,
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr1:161275906
GRCh38:
Chr1:161306116
MPZG213RNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I,
Inborn genetic diseases, not provided, not specified,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Conflicting interpretations of pathogenicity
(Oct 3, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr1:161277149
GRCh38:
Chr1:161307359
MPZR45WCharcot-Marie-Tooth disease, type I, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2J,
Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Dejerine-Sottas disease, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E,
not provided
Conflicting interpretations of pathogenicity
(Oct 10, 2022)
criteria provided, conflicting interpretations
49.
GRCh37:
Chr1:161277092-161277094
GRCh38:
Chr1:161307302-161307304
MPZS63delCharcot-Marie-Tooth disease, type I, not providedPathogenic
(Nov 24, 2021)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr1:161276117
GRCh38:
Chr1:161306327
MPZnot providedPathogenic
(Nov 19, 2015)
criteria provided, single submitter
51.
GRCh37:
Chr1:161276543
GRCh38:
Chr1:161306753
MPZI135LCharcot-Marie-Tooth disease type 1BPathogenic
(Aug 18, 2015)
criteria provided, single submitter
52.
GRCh37:
Chr1:161279434-161299373
GRCh38:
Chr1:161309667-161329606
MPZ, SDHCCharcot-Marie-Tooth disease type 1BLikely pathogenic
(Sep 17, 2015)
criteria provided, single submitter
53.
GRCh37:
Chr1:161275597-161275598
GRCh38:
Chr1:161305807-161305808
MPZCharcot-Marie-Tooth disease type 1BLikely pathogenic
(Sep 17, 2015)
criteria provided, single submitter
54.
GRCh37:
Chr1:161277082
GRCh38:
Chr1:161307292
MPZR67HNeuropathy, congenital hypomyelinating, 2, not provided, not specified,
Inborn genetic diseases, Charcot-Marie-Tooth disease, type I, Roussy-Lévy syndrome,
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D
Conflicting interpretations of pathogenicity
(Oct 19, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr1:161275763-161275777
GRCh38:
Chr1:161305973-161305987
MPZCharcot-Marie-Tooth disease type 1BPathogenic
(Aug 7, 2015)
criteria provided, single submitter
56.
GRCh37:
Chr1:161276536
GRCh38:
Chr1:161306746
MPZG137DCharcot-Marie-Tooth disease type 1BPathogenic
(Sep 3, 2015)
criteria provided, single submitter
57.
GRCh37:
Chr1:161276252
GRCh38:
Chr1:161306462
MPZP151TCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 2I,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome, Dejerine-Sottas disease, not provided
Conflicting interpretations of pathogenicity
(Sep 2, 2021)
criteria provided, conflicting interpretations
58.
MPZCharcot-Marie-Tooth disease type 1BPathogenic
(Dec 18, 2014)
no assertion criteria provided
59.
GRCh37:
Chr1:161276204
GRCh38:
Chr1:161306414
MPZG167RCharcot-Marie-Tooth disease, type IPathogenic
(Dec 24, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr1:161276216
GRCh38:
Chr1:161306426
MPZG163RCharcot-Marie-Tooth disease, type IPathogenic
(Sep 29, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr1:161276705
Chr1:161276609
GRCh38:
Chr1:161306915
Chr1:161306819
MPZ, MPZH81Y, V113FCharcot-Marie-Tooth disease type 1BPathogenic
(Mar 26, 2015)
no assertion criteria provided
62.
GRCh37:
Chr1:161277101
GRCh38:
Chr1:161307311
MPZD61NCharcot-Marie-Tooth disease, type I, not providedPathogenic
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr1:161275943
GRCh38:
Chr1:161306153
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2J,
Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, not specified,
Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D,
Roussy-Lévy syndrome
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr1:161275729
GRCh38:
Chr1:161305939
MPZNeuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I,
not specified, not provided, Charcot-Marie-Tooth disease type 4E,
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr1:161275764
GRCh38:
Chr1:161305974
MPZP217SCharcot-Marie-Tooth diseaseUncertain significanceno assertion criteria provided
66.
GRCh37:
Chr1:161275897
GRCh38:
Chr1:161306107
MPZCharcot-Marie-Tooth diseaseUncertain significanceno assertion criteria provided
67.
GRCh37:
Chr1:161276599
GRCh38:
Chr1:161306809
MPZN116SInborn genetic diseases, Charcot-Marie-Tooth disease, type I, not provided,
Charcot-Marie-Tooth disease type 2I
Uncertain significance
(Oct 8, 2021)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr1:161277118
GRCh38:
Chr1:161307328
MPZS55ICharcot-Marie-Tooth diseaseUncertain significanceno assertion criteria provided
69.
GRCh37:
Chr1:161275743
GRCh38:
Chr1:161305953
MPZD224YInborn genetic diseases, Charcot-Marie-Tooth disease, type IPathogenic/Likely pathogenic
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr1:161275954-161275955
GRCh38:
Chr1:161306164-161306165
MPZM197fsCharcot-Marie-Tooth disease type 1Bnot providedno assertion provided
71.
GRCh37:
Chr1:161276216
GRCh38:
Chr1:161306426
MPZG163RInborn genetic diseases, Charcot-Marie-Tooth disease, type I, not provided
Pathogenic/Likely pathogenic
(Oct 9, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr1:161276557
GRCh38:
Chr1:161306767
MPZK130RCharcot-Marie-Tooth disease, type I, not provided, Charcot-Marie-Tooth disease type 1B
Conflicting interpretations of pathogenicity
(Aug 9, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr1:161276609
GRCh38:
Chr1:161306819
MPZV113FCharcot-Marie-Tooth disease, type I, not providedUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr1:161276640
GRCh38:
Chr1:161306850
MPZD104fsCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease dominant intermediate DPathogenic/Likely pathogenic
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr1:161276680
GRCh38:
Chr1:161306890
MPZI89TCharcot-Marie-Tooth disease type 1Bnot providedno assertion provided
76.
GRCh37:
Chr1:161276702
GRCh38:
Chr1:161306912
MPZY82HCharcot-Marie-Tooth disease, type I, not providedPathogenic
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr1:161276705
GRCh38:
Chr1:161306915
MPZH81YCharcot-Marie-Tooth diseaseUncertain significance
(Aug 14, 2019)
no assertion criteria provided
78.
GRCh37:
Chr1:161277107
GRCh38:
Chr1:161307317
MPZS59TCharcot-Marie-Tooth disease type 1Bnot providedno assertion provided
79.
GRCh37:
Chr1:161277193
GRCh38:
Chr1:161307403
MPZI30TCharcot-Marie-Tooth disease, type ILikely pathogenic
(Aug 16, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr1:161276670
GRCh38:
Chr1:161306880
MPZCharcot-Marie-Tooth disease, type ILikely pathogenic
(Dec 24, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr1:161276579
GRCh38:
Chr1:161306789
MPZG123SCharcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 1BConflicting interpretations of pathogenicity
(Jan 22, 2008)
no assertion criteria provided
82.
GRCh37:
Chr1:161277104
GRCh38:
Chr1:161307314
MPZD60HCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1BConflicting interpretations of pathogenicity
(Aug 4, 2022)
criteria provided, conflicting interpretations
83.
GRCh37:
Chr1:161276512
GRCh38:
Chr1:161306722
MPZY145SCharcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 2I,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 4E,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type I, not provided
Pathogenic
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr1:161277049
GRCh38:
Chr1:161307259
MPZS78LCharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease, not provided,
Charcot-Marie-Tooth disease type 1B
Pathogenic
(Jun 1, 2023)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr1:161276638
GRCh38:
Chr1:161306848
MPZG103EInborn genetic diseases, Charcot-Marie-Tooth disease, type I, not provided
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr1:161276553
GRCh38:
Chr1:161306763
MPZN131Knot provided, Charcot-Marie-Tooth disease, type IPathogenic
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr1:161277151
GRCh38:
Chr1:161307361
MPZS44Fnot provided, Inborn genetic diseases, Charcot-Marie-Tooth disease,
Charcot-Marie-Tooth disease, type I
Pathogenic
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr1:161277058
GRCh38:
Chr1:161307268
MPZD75VCharcot-Marie-Tooth disease, type IPathogenic
(Aug 30, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr1:161276575
GRCh38:
Chr1:161306785
MPZT124Mnot provided, Charcot-Marie-Tooth disease dominant intermediate D, Inborn genetic diseases,
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 2I,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 4E, Dejerine-Sottas disease,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type I ...see more
Pathogenic
(Jul 1, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr1:161276704
GRCh38:
Chr1:161306914
MPZH81RCharcot-Marie-Tooth disease, type I, not providedPathogenic
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr1:161277094
GRCh38:
Chr1:161307304
MPZS63FCharcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type IPathogenic/Likely pathogenic
(Aug 12, 2021)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr1:161276653
GRCh38:
Chr1:161306863
MPZR98HInborn genetic diseases, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease,
not provided, Charcot-Marie-Tooth disease type 1B, Pes cavus,
Distal muscle weakness, Decreased nerve conduction velocity, Sensory neuropathy,
Distal lower limb amyotrophy
Pathogenic/Likely pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr1:161276654
GRCh38:
Chr1:161306864
MPZR98Cnot provided, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease, type I
Pathogenic
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr1:161276653
GRCh38:
Chr1:161306863
MPZR98PInborn genetic diseases, not provided, Charcot-Marie-Tooth disease, type I
Pathogenic/Likely pathogenic
(Jul 8, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr1:161276537
GRCh38:
Chr1:161306747
MPZG137SCharcot-Marie-Tooth disease, type I, not providedLikely pathogenic
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr1:161276542
GRCh38:
Chr1:161306752
MPZI135Tnot provided, Dejerine-Sottas diseasePathogenic/Likely pathogenic
(Jan 3, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr1:161275766-161275774
GRCh38:
Chr1:161305976-161305984
MPZCharcot-Marie-Tooth disease type 1BPathogenic
(Nov 15, 1993)
no assertion criteria provided
98.
GRCh37:
Chr1:161276204
GRCh38:
Chr1:161306414
MPZG167RCharcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 2I,
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 4E,
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type I
Pathogenic
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr1:161276676
GRCh38:
Chr1:161306886
MPZD90ECharcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1BPathogenic
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr1:161276660
GRCh38:
Chr1:161306870
MPZK96ECharcot-Marie-Tooth disease, type IPathogenic
(Aug 24, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination